PDGFRB and angiosarcoma: This resulted in 75% of Pdgfrb-Cre, Trp53R172H/R172H mice developing angiosarcomas, which is higher than the 62% reported when Tie2-Cre mice were crossed to Trp53 floxed mice (Farhang Ghahremani et al., 2014).